← Every company
Organon & Co Lobbying
What Organon & Co discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
OGN on carbonthat →Disclosed spend
$930K
across every filing on file
Filings
10
Years covered
1
Firms retained
4
What it lobbies about
Health IssuesMedicare/MedicaidBudget/AppropriationsPharmacy
10 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20261st Quarter (Jan 1 - Mar 31) | ORGANON & CO.Budget/AppropriationsMedicare/Medicaid | $320K |
| 20262nd Quarter (Apr 1 - June 30) | ORGANON & CO.Medicare/MedicaidBudget/Appropriations | $320K |
| 20262nd Quarter (Apr 1 - June 30) | TIBER CREEK GROUPHealth IssuesMedicare/Medicaid | $60K |
| 20261st Quarter (Jan 1 - Mar 31) | TIBER CREEK GROUPHealth IssuesMedicare/Medicaid | $60K |
| 20262nd Quarter (Apr 1 - June 30) | WILLIAMS AND JENSEN, PLLCBudget/AppropriationsHealth Issues | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | WILLIAMS AND JENSEN, PLLCHealth IssuesBudget/Appropriations | $50K |
| 20261st Quarter (Jan 1 - Mar 31) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | B HALL STRATEGIES, LLCPharmacy | $30K |
| 20262nd Quarter (Apr 1 - June 30) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health IssuesMedicare/Medicaid | $5K |
| 20261st Quarter (Jan 1 - Mar 31) | JEFFREY J. KIMBELL & ASSOCIATES, INC.Health IssuesMedicare/Medicaid | $5K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on OGN
Company overviewEverything on OGN in one place, with the price.SEC filingsWhat OGN's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat OGN's own officers and directors buy and sell.Who owns itEvery manager reporting a position in OGN.Funds holding itWhich funds and ETFs hold OGN, and how big a bet.Who lobbies for itThe lobbyists on OGN's account, and who they worked for.Federal contractsWhat federal agencies pay OGN.PatentsWhat OGN is filing at the patent office.